Biogen Inc.

10% OwnerSANGAMO THERAPEUTICS, INC (SGMO) · full profile →Form 4 · filed Dec 28, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$699K
Net Open-Market Flow
-$699K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 27, 2021Sell(S)600$8.56$5K24.2M
Dec 23, 2021Sell(S)81K$8.55$694K24.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875045-21-000060) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.